Diabetes is a disease characterized by abnormally high blood glucose levels. This disease is considered to be one of the major epidemics of the 21st century. Diabetes can cause complications in many parts of the body, increasing the overall risk of premature death (world diabetes report, WHO, 2016).
more than 1
million type 1 diabetics [20-79 years] worldwide in 2017
more than 1099965
children [0-19 years] are affected by this disease
in about 10
percent of these patients, the regulation of glycated hemoglobin levels (> 8%) is poor
Auto-immune destruction of pancreatic beta cells producing insulin = insulin dependent
The body no longer produces insulin
5-10% of patients with diabetes
Often diagnosed among children or teenagers
Sudden onset of symptoms
Must inject insulin daily
Diabetics have to measure the amount of glucose in the blood several times a day. Recently, continuous glucose monitoring (CGM) devices have arrived on the market, making it easier to check blood glucose levels while reducing the number of measurements that need to be taken each day. The amount of insulin that the patient has to inject depends on these readings. There are several ways available to them to do this:
Defymed is a French SME that develops innovative medical devices aimed at treating patients physiologically in order to improve the clinical effectiveness of their treatment as well as their comfort.
There are currently two medical devices being developed by Defymed which are at an advanced preclinical trial phase: